HDOC
Investment Objective
HDOC seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the field of telemedicine and digital health, as well as applications thereof. Currently, HDOC seeks to replicate, directly or indirectly, the performance of the Solactive Telemedicine & Digital Health Index, net of expenses, by investing primarily in the Global X Telemedicine & Digital Health ETF. HDOC seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.
Fund Details
Ticker
HDOC
Inception Date
December 01, 2021
Net Assets ?
$1,082,954
As at August 08, 2023
Consolidated Prior Day Volume ?
158
For August 15, 2023
Average Daily Trading Volume Over a 12 Month Period ?
185
As at August 15, 2023
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOLEDOC
Management Fee
0.60%
(Plus applicable sales taxes)
Management Expense Ratio ?
0.71%
As at December 31, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
549300FXC4EUMR8AID94
Distribution Metrics
Most Recent Distributions Per Unit
$--
12-Month Trailing Yield ?
-- %
Distribution Frequency
Annually
Reinvested Non-Cash Distributions
0.64456
Record Date
December 31, 2021
The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.
The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.
Annualized Performance (%) *
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Calendar Year Performance (%) *
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Distributions
| Year | Ex-Dividend Date | Record Date | Payment Date | Payment Amount | Reinvested Non-Cash Distributions | Distribution Period |
|---|---|---|---|---|---|---|
| 2021 | 12/30/2021 | 12/31/2021 | 01/13/2022 | 0.64456 | Annually |
Top 10 Holdings
As at August 31, 2023| Security Name | Weight |
|---|---|
| R1 RCM Inc | 5.03% |
| Pacific Biosciences of California Inc | 5.02% |
| AMN Healthcare Services Inc | 4.56% |
| Privia Health Group Inc | 4.44% |
| Omnicell Inc | 4.27% |
| Laboratory Corp of America Hldgs | 4.17% |
| Agilent Technologies Inc | 4.04% |
| Veracyte Inc | 3.93% |
| Teladoc Health Inc | 3.90% |
| Alibaba Health Information Tech Ltd | 3.65% |
Education
Regulatory and Legal
At a Glance
Investment Objective
HDOC seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the field of telemedicine and digital health, as well as applications thereof. Currently, HDOC seeks to replicate, directly or indirectly, the performance of the Solactive Telemedicine & Digital Health Index, net of expenses, by investing primarily in the Global X Telemedicine & Digital Health ETF. HDOC seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.
Product Facts
Fund Details
Ticker
HDOC
Inception Date
December 01, 2021
Net Assets ?
$1,082,954
As at August 08, 2023
Consolidated Prior Day Volume ?
158
ForAugust 15, 2023
Average Daily Trading Volume Over a 12 Month Period ?
185
As at August 15, 2023
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOLEDOC
Management Fee
0.60%
(Plus applicable sales taxes)
Management Expense Ratio ?
0.71%
As at December 31, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
549300FXC4EUMR8AID94
Distribution Metrics
As at August 01, 2023
Most Recent Distributions Per Unit
--
Annualized Distribution Yield ?
-- %
As at August 01, 2023
12-Month Trailing Yield ?
-- %
Distribution Frequency
Annually
Reinvested Non-Cash Distributions
0.64456
Record Date
December 31, 2021
The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.
The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.
Performance & Distributions
Annualized Performance (%)
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Calendar Year Performance (%)
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Distributions
| Year | Ex-Dividend Date | Record Date | Payment Date | Payment Amount | Reinvested Non-Cash Distributions | Distribution Period |
|---|---|---|---|---|---|---|
| 2021 | 12/30/2021 | 12/31/2021 | 01/13/2022 | 0.64456 | Annually |
Holdings
Top 10 Holdings
As at August 31, 2023| Security Name | Weight |
|---|---|
| R1 RCM Inc | 5.03% |
| Pacific Biosciences of California Inc | 5.02% |
| AMN Healthcare Services Inc | 4.56% |
| Privia Health Group Inc | 4.44% |
| Omnicell Inc | 4.27% |
| Laboratory Corp of America Hldgs | 4.17% |
| Agilent Technologies Inc | 4.04% |
| Veracyte Inc | 3.93% |
| Teladoc Health Inc | 3.90% |
| Alibaba Health Information Tech Ltd | 3.65% |
Documents
